期刊文献+

肠道菌群对半枝莲中活性成分的代谢及其抑制CYP1A1酶的影响 被引量:4

Gut Microbiota Mediated Metabolism and CYP1A1 Inhibition Effects of Scutellaria Barbata D.Don
下载PDF
导出
摘要 目的研究半枝莲提取物经肠道菌转化前后主要化学成分含量的变化及其对CYP1A1酶抑制能力的影响。方法采用超高效液相色谱串联三重四级杆质谱(UPLC-Q-TRAP-MS)技术检测半枝莲提取液在肠道菌中温孵0、0.5、1、2、4、6、12、24 h后主要活性成分的经时变化过程;通过CYP1A1酶活性分析实验研究半枝莲提取液经肠道菌转化不同时间点后对CYP1A1酶抑制作用的变化,并进一步研究半枝莲中主要黄酮类成分,野黄芩素、木犀草素、汉黄芩素及其苷对CYP1A1酶的抑制作用;利用分子对接验证野黄芩素、木犀草素、汉黄芩素与CYP1A1之间的结合情况。结果半枝莲提取液经过肠道菌转化后,野黄芩素含量先增加后减少,木犀草素、汉黄芩素含量增加,黄酮苷类成分野黄芩苷、木犀草苷、汉黄芩苷含量随时间延长显著减少,而二萜类成分半枝莲碱A、半枝莲碱B、半枝莲碱X含量无明显变化;半枝莲提取液经肠道菌温孵2、4、6 h后对CYP1A1酶活性的抑制作用增强,而12 h后这种增强作用逐渐减弱;野黄芩素、木犀草素、汉黄芩素与CYP1A1蛋白对接后的结合自由能分别为-6.33、-6.61、-7.09 kcal/mol,配体与CYP1A1中Phe224形成的π-π堆积作用为主要相互作用。结论半枝莲中的黄酮类化合物是其发挥抑制CYP1A1酶活作用的主要活性物质,可能与半枝莲的清热解毒功效有关。 OBJECTIVE To study gut microbiota mediated the changes in the concentration of main chemical components of Scutellaria barbata D.Don(S.barbata)and the vary of its inhibitory effect on CYP1A1 enzyme.METHODS Ultra-fast liquid chromatography coupled with quadrupole linear ion trap mass spectrometry(UPLC-Q-TRAP-MS)was established to quantify the constituents in co-incubation solution.CYP1A1 activity assay was used to detect the inhibitory effect of co-incubation extract,scutellarein,luteolin and wogonin on CYP1A1 enzyme.Molecular docking was used to study the binding of ligand to CYP1A1.RESULTS After the S.barbata extract was transformed by intestinal bacteria,the content of cutellarein increased at the earliest stage and then decreased,the content of luteolin and wogonin were increased,the content of scutellarin,luteoloside and wogonoside were decreased.Additionally,there was no significant change in the content of Scutebarbatine A,B,and X.The inhibitory effect of S.barbata extract on CYP1A1 enzyme activity was increased after incubating with intestinal bacteria for 2,4,6 h,and this enhancement decreased after 12 h.The binding energy between scutellarin,luteolin,wogonin with human CYP1A1 were-6.33,-6.61 and-7.09 kcal/mol,respectively.The main interaction was the formation ofπ-πstacking between the ligand and Phe224 of CYP1A1.CONCLUSION The flavonoids in S.barbata might be the main active substances that inhibit CYP1A1 enzyme activity.
作者 蒋家璐 孙溧 倪姐 徐坠成 宋蒙蒙 姚卫峰 程海波 康安 孙东东 JIANG Jia-lu;SUN Li;NI Jie;XU Zhui-cheng;SONG Meng-meng;YAO Wei-feng;CHENG Hai-bo;KANG An;SUN Dong-dong(School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China;Collaborative Innovation Center of Jiangsu Province of Cancer Prevention and Treatment of Chinese Medicine, Nanjing, 210023, China;School of Chinese Medicine, School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China)
出处 《南京中医药大学学报》 CAS CSCD 北大核心 2021年第2期225-230,共6页 Journal of Nanjing University of Traditional Chinese Medicine
基金 国家自然科学基金(81673559,81930117,81973523) 国家重点研发计划课题(2017YFC1700602) 江苏省自然科学基(BK20171491) 江苏省中医药管理局科研项目(YB201809) 江苏高校优势学科建设工程资助项目(PAPD)。
关键词 肠道菌 半枝莲 CYP1A1酶 分子对接 gut microbiome Scutellaria barbata D.Don CYP1A1 enzyme molecular docking
  • 相关文献

参考文献3

二级参考文献20

  • 1Hawrelak JA,Myers SP. The causes of intestinal dysbiosis:a re- view[J].Ahem Med Rev,2004,9( 2): 180-197.
  • 2Zhang X,Zhao YF, Zhang MH, et al. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats[J].PLoS One,2012,7 (8) :e42529.
  • 3Tsutomu O, Hisayuki T, Yoshio T. Studies on the absorption, distribution,excretion and metabolism of Ginseng Saponinso II.The absorption,distribution and excretion of ginsenoside Rgl in the rat[J]. Chem Pharm Bu11,1983,31(1):292-298.
  • 4Tsutomu O, Hisayuki T, Yoshio T. Studies on the absorption, distribution,excretion and Metabolism of Ginseng Saponinso IV. Decomposition of ginsenoside-Rgl and -Rbx in the digestive tract of rats[J]. Chem Pharm Bu11,1983,31(10):3691-3697.
  • 5Xu RJ ,Peng Y, Wang MY, et al. Effects of broad-spectrum anti- biotics on the metabolism and pharmacokinetics of ginsenoside Rbl :A study on rats' gut microflora influenced by lincomycin [J]. J Ethnopharmacol, 2014,158 : 338-344.
  • 6Zhao CY,Sun RB,Cao B,et al. An in vitro metabolic system of gut flora and the metabolism of ginsenoside Rga and cholic acid [J]. Eur J Drug Metab Pharmacokinet,2014,39(2):129-137.
  • 7Niu T, Smith DL, Yang Z, et al. Bioactivity and bioavailability of ginsenosides are dependent on theglycosidase activities of the A/ J mouse intestinal microbiome defined by pyrosequencing[J]. Pharm Res, 2013,30(3) : 836-846.
  • 8Wan JY, Hua HY, Liu XY, et al. In vitro biotransformation of red ginseng extract by human intestinalmicroflora, Metabolites identification and metabolic profileelucidation using LC-Q-TOF/ MS[J]. J Pbarm Biomed Anal,2014,98:296-306.
  • 9Wan JY,Liu P, Wang HY, et al. Biotransformation and meta bolic profile of American ginseng saponins with human intesti- nal microflora by liquid chromatography quadrupole time-of flight mass spectrometry[J]. J Chromatograp A, 2013,1286 : 83 -92.
  • 10Bae EA,Han MJ,Choo MK,et al. Metabolism of 20(S)-and 20 (R) -ginsenoside Rga by human intestinal bacteria and its rela- tion to in vitro biological activities[J]. Biol Pharm Bull, 2002, 25(1) :58-63.

共引文献24

同被引文献70

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部